Trials / Unknown
UnknownNCT01577056
Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Effect of Fish Oil Supplementation on Postprandial Lipid Metabolism in Familial Hypercholesterolaemia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- The University of Western Australia · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether fish oil supplementation is effective in the treatment of abnormal fat metabolism in subjects with elevated cholesterolaemia.
Detailed description
The use of statin therapy in familial hypercholesterolaemia (FH) is known to reduce cardiovascular risk and is a first line recommendation, however, there is considerable residual risk predicted by the presence of fasting and post-prandial hypertriglyceridaemia. This study will examine the effect of oral n-3 fatty acid ethyl esters supplementation (4g/day, Omacor) on postprandial hypertriglyceridaemia and post-prandial arterial function when administrated to FH patients at increased risk of cardiovascular disease due to their residual fasting hypertriglyceridaemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Fish oil capsule | 4g Omega capsule for 12 weeks |
| DRUG | HMG Coenzyme reductase | All FH subjects are on standard statin treatment during study period |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-12-01
- Completion
- 2014-03-01
- First posted
- 2012-04-13
- Last updated
- 2012-04-13
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01577056. Inclusion in this directory is not an endorsement.